Pupil dilation

Pupil dilation is the widening of the pupil beyond its resting diameter under the influence of a psychoactive substance.

As a drug effect it is acute and dose-proportional, resolving as the substance wears off; this distinguishes it from persistent mydriasis caused by injury, neurological disease, or topical agents. It ranges from a small, barely noticeable enlargement to near-complete dilation that makes bright environments uncomfortable.

Pupil dilation is among the most consistently observed physiological signs of intoxication across drug classes. It is most commonly induced at moderate to high doses under psychedelics such as LSD, psilocybin mushrooms, and DMT, and under stimulants such as amphetamine, MDMA, and modafinil. It also appears under dissociatives such as ketamine, dextromethorphan, and 3-MeO-PCP, and under depressants including GHB, baclofen, and GBL.

Pupil dilation is felt as a shift in how light reaches the eye rather than any sensation in the iris itself: ambient scenes appear brighter and more saturated, light sources seem to bloom or acquire faint halos, and peripheral sensitivity increases.

In bright conditions this can tip into squinting or mild photophobia. Mirrors and direct eye contact become noticeably altered — the widened, darkened iris is conspicuous to the person and to others alike. At high doses under psychedelics or stimulants, ordinary indoor lighting can feel unexpectedly harsh.

Pupil dilation arises through different pathways depending on the drug class:

• Psychedelics — 5-HT2A agonism activates sympathetic outflow to the iris dilator muscle, producing mydriasis proportional to dose.
• Stimulants — elevate norepinephrine and dopamine, stimulating sympathetic receptors in the dilator and suppressing parasympathetic tone.
• Dissociatives — combine NMDA antagonism with sympathomimetic activity, both of which promote pupil widening.
• Depressants — reduced inhibitory tone on sympathetic outflow likely underlies the effect rather than direct receptor activation.

How much each pathway contributes in a given case is not fully understood.

Who experiences it, and how strongly, varies with dose above all — dilation scales closely with blood concentration across most classes. Baseline pupil size differs between individuals, limiting the visible range in those with naturally larger pupils.

Bright ambient light partially counteracts dilation through the pupillary light reflex, making the effect most apparent in dim settings. Individual autonomic tone and prior stimulant tolerance modulate extent, and certain medications acting on the iris can compound or mask it.